Ind-Swift Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ind-Swift Limited with three other
companies in this sector in India:
Themis Medicare Limited
sales of 2.46 billion Indian Rupees [US$37.85 million]
Astec LifeSciences Limited
(2.99 billion Indian Rupees [US$46.00 million]
Gufic Biosciences Ltd
(2.49 billion Indian Rupees [US$38.39 million]
Ind-Swift Limited reported sales of 2.67 billion Indian Rupees (US$41.15 million)
March of 2017.
decrease of 12.2%
versus 2016, when the company's sales were 3.04 billion Indian Rupees.